{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:07:42Z","timestamp":1791929262768,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recent single-center reports have suggested that community-acquired bacteremic co-infection in the context of Coronavirus disease 2019 (COVID-19) may be an important driver of mortality; however, these reports have not been validated with a multicenter, demographically diverse, cohort study with data spanning the pandemic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this multicenter, retrospective cohort study, inpatient encounters were assessed for COVID-19 with community-acquired bacteremic co-infection using 48-h post-admission blood cultures and grouped by: (1) confirmed co-infection [recovery of bacterial pathogen], (2) suspected co-infection [negative culture with\u2009\u2265\u20092 antimicrobials administered], and (3) no evidence of co-infection [no culture]. The primary outcomes were in-hospital mortality, ICU admission, and mechanical ventilation. COVID-19 bacterial co-infection risk factors and impact on primary outcomes were determined using multivariate logistic regressions and expressed as adjusted odds ratios with 95% confidence intervals (Cohort, OR 95% CI, Wald test\n                      <jats:italic>p<\/jats:italic>\n                      value).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The studied cohorts included 13,781 COVID-19 inpatient encounters from 2020 to 2022 in the University of Alabama at Birmingham (UAB,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20094075) and Ochsner Louisiana State University Health\u2014Shreveport (OLHS,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20099706) cohorts with confirmed (2.5%), suspected (46%), or no community-acquired bacterial co-infection (51.5%) and a comparison cohort consisting of 99,170 inpatient encounters from 2010 to 2019 (UAB pre-COVID-19 pandemic cohort). Significantly increased likelihood of COVID-19 bacterial co-infection was observed in patients with elevated\u2009\u2265\u200915 neutrophil-to-lymphocyte ratio (UAB: 1.95 [1.21\u20133.07]; OLHS: 3.65 [2.66\u20135.05],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001 for both) within 48-h of hospital admission. Bacterial co-infection was found to confer the greatest increased risk for in-hospital mortality (UAB: 3.07 [2.42\u20135.46]; OLHS: 4.05 [2.29\u20136.97],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001 for both), ICU admission (UAB: 4.47 [2.87\u20137.09], OLHS: 2.65 [2.00\u20133.48],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001 for both), and mechanical ventilation (UAB: 3.84 [2.21\u20136.12]; OLHS: 2.75 [1.87\u20133.92],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001 for both) across both cohorts, as compared to other risk factors for severe disease. Observed mortality in COVID-19 bacterial co-infection (24%) dramatically exceeds the mortality rate associated with community-acquired bacteremia in pre-COVID-19 pandemic inpatients (5.9%) and was consistent across alpha, delta, and omicron SARS-CoV-2 variants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Elevated neutrophil-to-lymphocyte ratio is a prognostic indicator of COVID-19 bacterial co-infection within 48-h of admission. Community-acquired bacterial co-infection, as defined by blood culture-positive results, confers greater increased risk of in-hospital mortality, ICU admission, and mechanical ventilation than previously described risk factors (advanced age, select comorbidities, male sex) for COVID-19 mortality, and is independent of SARS-CoV-2 variant.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-023-04312-0","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:02:32Z","timestamp":1674432152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation"],"prefix":"10.1186","volume":"27","author":[{"given":"Michael John","family":"Patton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos J.","family":"Orihuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin S.","family":"Harrod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad A. N.","family":"Bhuiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paari","family":"Dominic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Kevil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Fort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent X.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Farhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Koff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charitharth V.","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuj","family":"Gaggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Erdmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Might","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Gaggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"key":"4312_CR1","unstructured":"World Health Organization. Weekly epidemiological update on COVID-19 - 3 August 2022. Emergency Situational Updates, 2022; 103. http:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports"},{"key":"4312_CR2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054\u201362.","journal-title":"Lancet"},{"key":"4312_CR3","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41586-020-2818-3","volume":"587","author":"H Zeberg","year":"2020","unstructured":"Zeberg H, P\u00e4\u00e4bo S. The major genetic risk factor for severe COVID-19 is inherited from Neanderthals. Nature. 2020;587:610\u20132.","journal-title":"Nature"},{"key":"4312_CR4","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1186\/s12879-021-06536-3","volume":"21","author":"ZG Dessie","year":"2021","unstructured":"Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and metaanalysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021;21:855.","journal-title":"BMC Infect Dis"},{"key":"4312_CR5","doi-asserted-by":"publisher","first-page":"e354","DOI":"10.1016\/S2666-5247(21)00090-2","volume":"2","author":"CD Russell","year":"2021","unstructured":"Russell CD, Fairfield CJ, Drake TM, et al. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study. Lancet Microbe. 2021;2:e354\u201365.","journal-title":"Lancet Microbe"},{"key":"4312_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ijid.2022.03.003","volume":"118","author":"E Moreno-Garc\u00eda","year":"2022","unstructured":"Moreno-Garc\u00eda E, Puerta-Alcalde P, Letona L, et al. Bacterial co-infection at hospital admission in patients with COVID-19. Int J Infect Dis. 2022;118:197\u2013202.","journal-title":"Int J Infect Dis"},{"key":"4312_CR7","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","volume":"26","author":"BJ Langford","year":"2020","unstructured":"Langford BJ, So M, Raybardhan S, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26:1622\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"4312_CR8","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.3390\/ijerph19042424","volume":"19","author":"A Alqahtani","year":"2022","unstructured":"Alqahtani A, Alamer E, Mir M, et al. Bacterial Coinfections Increase Mortality of Severely Ill COVID-19 Patients in Saudi Arabia. Int J Environ Res Public Health. 2022;19:2424.","journal-title":"Int J Environ Res Public Health"},{"key":"4312_CR9","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1002\/iub.2356","volume":"72","author":"R Mirzaei","year":"2020","unstructured":"Mirzaei R, Goodarzi P, Asadi M, et al. Bacterial co-infections with SARS-CoV-2. IUBMB Life. 2020;72:2097\u2013111.","journal-title":"IUBMB Life"},{"key":"4312_CR10","first-page":"2459","volume":"71","author":"TM Rawson","year":"2020","unstructured":"Rawson TM, Moore LSP, Zhu N, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71:2459\u201368.","journal-title":"Clin Infect Dis"},{"key":"4312_CR11","doi-asserted-by":"publisher","first-page":"198005","DOI":"10.1016\/j.virusres.2020.198005","volume":"285","author":"X Zhu","year":"2020","unstructured":"Zhu X, Ge Y, Wu T, et al. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res. 2020;285:198005.","journal-title":"Virus Res"},{"key":"4312_CR12","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.cmi.2020.06.025","volume":"26","author":"S Hughes","year":"2020","unstructured":"Hughes S, Troise O, Donaldson H, Mughal N, Moore LSP. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect. 2020;26:1395\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"4312_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cmi.2020.07.041","volume":"27","author":"C Garcia-Vidal","year":"2021","unstructured":"Garcia-Vidal C, Sanjuan G, Moreno-Garc\u00eda E, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021;27:83\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"4312_CR14","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.tim.2021.03.018","volume":"29","author":"LF Westblade","year":"2021","unstructured":"Westblade LF, Simon MS, Satlin MJ. Bacterial coinfections in coronavirus disease 2019. Trends Microbiol. 2021;29:930\u201341.","journal-title":"Trends Microbiol"},{"key":"4312_CR15","first-page":"359","volume":"56","author":"L Fattorini","year":"2020","unstructured":"Fattorini L, Creti R, Palma C, et al. Bacterial coinfections in COVID-19: an underestimated adversary. Annali dell\u2019Istituto superiore di sanita. 2020;56:359\u201364.","journal-title":"Annali dell\u2019Istituto superiore di sanita"},{"key":"4312_CR16","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1001\/jama.2020.6266","volume":"323","author":"D Kim","year":"2020","unstructured":"Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. J Am Med Assoc. 2020;323:2085\u20136.","journal-title":"J Am Med Assoc"},{"key":"4312_CR17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12879-022-07089-9","volume":"22","author":"P Hedberg","year":"2022","unstructured":"Hedberg P, Johansson N, Ternhag A, Abdel-Halim L, Hedlund J, Naucl\u00e9r P. Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus. BMC Infect Dis. 2022;22:108.","journal-title":"BMC Infect Dis"},{"key":"4312_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","volume":"81","author":"L Lansbury","year":"2020","unstructured":"Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81:266\u201375.","journal-title":"J Infect"},{"key":"4312_CR19","doi-asserted-by":"crossref","unstructured":"Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009;64 Suppl 3:iii1\u201355.","DOI":"10.1136\/thx.2009.121434"},{"key":"4312_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jama.2012.194139","volume":"309","author":"DS Chertow","year":"2013","unstructured":"Chertow DS, Memoli MJ. Bacterial coinfection in influenza: a grand rounds review. J Am Med Assoc. 2013;309:275\u201382.","journal-title":"J Am Med Assoc"},{"issue":"9","key":"4312_CR21","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1017\/ice.2021.341","volume":"43","author":"LA Petty","year":"2022","unstructured":"Petty LA, Flanders SA, Vaughn VM, Ratz D, O'Malley M, Malani AN, Washer L, Kim T, Kocher KE, Kaatz S, Czilok T, McLaughlin E, Prescott HC, Chopra V, Gandhi T. Risk factors and outcomes associated with community-onset and hospital-acquired coinfection in patients hospitalized for coronavirus disease 2019 (COVID-19): A multihospital cohort study. Infect Control Hosp Epidemiol. 2022;43(9):1184\u201393. https:\/\/doi.org\/10.1017\/ice.2021.341.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"4312_CR22","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jama.2016.0288","volume":"315","author":"CW Seymour","year":"2016","unstructured":"Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). J Am Med Assoc. 2016;315:762\u201374.","journal-title":"J Am Med Assoc"},{"key":"4312_CR23","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","volume":"101","author":"RC Bone","year":"1992","unstructured":"Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101:1644\u201355.","journal-title":"Chest"},{"key":"4312_CR24","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of covid-19\u2014final report. N Engl J Med. 2020;383:1813\u201326.","journal-title":"N Engl J Med"},{"key":"4312_CR25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"4312_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1365-2141.1977.tb00646.x","volume":"36","author":"JM Mishler","year":"1977","unstructured":"Mishler JM, Emerson PM. Development of Neutrophilia by serially increasing doses of dexamethasone. Br J Haematol. 1977;36:249\u201357.","journal-title":"Br J Haematol"},{"key":"4312_CR27","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1093\/jac\/dkaa563","volume":"76","author":"CY Mason","year":"2021","unstructured":"Mason CY, Kanitkar T, Richardson CJ, et al. Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics. J Antimicrob Chemother. 2021;76:1323\u201331.","journal-title":"J Antimicrob Chemother"},{"key":"4312_CR28","doi-asserted-by":"publisher","first-page":"100955","DOI":"10.1016\/j.eclinm.2021.100955","volume":"37","author":"Y Liu","year":"2021","unstructured":"Liu Y, Ling L, Wong SH, et al. Outcomes of respiratory viral-bacterial co-infection in adult hospitalized patients. EClinicalMedicine. 2021;37:100955.","journal-title":"EClinicalMedicine"},{"key":"4312_CR29","doi-asserted-by":"publisher","first-page":"12703","DOI":"10.1038\/s41598-021-92220-0","volume":"11","author":"N Shafran","year":"2021","unstructured":"Shafran N, Shafran I, Ben-Zvi H, et al. Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients. Sci Rep. 2021;11:12703.","journal-title":"Sci Rep"},{"key":"4312_CR30","unstructured":"Centers for Disease Control and Prevention. COVID Data Tracker. Atlanta, GA: US Department of Health and Human Services, CDC;\u00a02022, October 12. https:\/\/covid.cdc.gov\/covid-data-tracker"},{"key":"4312_CR31","doi-asserted-by":"crossref","unstructured":"Cambier S, Metzemaekers M, Carvalho AC de, et al. Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza. JCI Insight 2022.","DOI":"10.1172\/jci.insight.155055"},{"key":"4312_CR32","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"P Horby","year":"2021","unstructured":"Group RC, Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with covid-19. N Engl J Med. 2021;384:693\u2013704.","journal-title":"N Engl J Med"},{"key":"4312_CR33","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa2031994","volume":"384","author":"AC Kalil","year":"2021","unstructured":"Kalil AC, Patterson TF, Mehta AK, et al. Baricitinib plus remdesivir for hospitalized adults with covid-19. N Engl J Med. 2021;384:795\u2013807.","journal-title":"N Engl J Med"},{"key":"4312_CR34","unstructured":"Wolfe CR, Tomashek KM, Patterson TF, et al. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial. Lancet. Respiratory medicine 2022."},{"key":"4312_CR35","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","volume":"397","author":"Group RC","year":"2021","unstructured":"Group RC. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021;397:1637\u201345.","journal-title":"Lancet"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04312-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-023-04312-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04312-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:05:12Z","timestamp":1674432312000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-023-04312-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4312"],"URL":"https:\/\/doi.org\/10.1186\/s13054-023-04312-0","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,23]]},"assertion":[{"value":"21 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The following retrospective multicenter study was designed and approved by the UAB and OLHS Institutional Review Boards (UAB IRBs: 300006291, 300006205; OLHS IRB: STUDY00001501).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}